SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Insmed Incorporated Announces CLEAR-108 Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections Has Completed Target Enrollment